Evidence map›Paper›PMID 41471385›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

In Silico Identification of Molecular Interactions of the Emerging Contaminant Octyl Methoxycinnamate (OMC) on HPT Axis: Implications for Humans and Zebrafish.

Margarida Lorigo, Luiza Breitenfeld, Marta S Monteiro, Amadeu M V M Soares, Carla Quintaneiro, Elisa Cairrao

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Margarida LorigoFCS-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0002-4752-6398
Luiza BreitenfeldFCS-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0001-8550-1645
Marta S MonteiroDepartment of Biology & CESAM (Centre for Environmental and Marine Studies), University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-1891-7365
Amadeu M V M SoaresDepartment of Biology & CESAM (Centre for Environmental and Marine Studies), University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-0879-9470
Carla QuintaneiroDepartment of Biology & CESAM (Centre for Environmental and Marine Studies), University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-1151-8177
Elisa CairraoFCS-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0002-4823-5701

Funding

Fundação para a Ciência e Tecnologia (2020.06616.BD, DOI: 10.54499/2020.06616.BD, M.L.)Fundação para a Ciência e Tecnologia (article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19, DOI: 10.54499/DL57/2016/CP1482/CT0160, C.Q.)Fundação para a Ciência e Tecnologia DOI 10.54499/UIDB/00709/2020 (https://doi.org/10.54499/UIDB/00709/2020) and DOI 10.54499/UIDP/00709/2020 (https://doi.org/10.54499/UIDP/00709/2020) CICSFundação para a Ciência e Tecnologia UID/50006 + LA/P/0094/2020 (CESAM)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADMET propertiesLipinski’s rule-of-fivemolecular dockingpropylthiouracilT3 hormonethyroid disruption

Identifiers

PMID41471385
PMCPMC12736302

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.